Efficacy of Individualized Rituximab in Maintaining Remission of Moderate and Severe Systemic Lupus Erythematosus
Condition: Autoimmune Diseases Interventions: Drug: Standard dose of rituximab; Drug: Individualized dose of rituximab Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials